Inventor · disambiguated record
Jaspal Singh Kang
Also filed as: KANG JASPAL S · KANG JASPAL SINGH
40 granted patents·15 pending applications·1,188 citations·filing 2002–2022
98Inventor score
Files withAMGEN FREMONT INC9INNOVATIVE TARGETING SOLUTIONS INC9MEDIMMUNE LTD6WEBER RICHARD5AMGEN INC3
Top patents by PatentIndex Score
55 records- 0197US7736644B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Jun 15, 2010·77 cites·115 claims
- 0297US7628986B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Dec 8, 2009·119 cites·83 claims
- 0396US8470330B2PSMA antibodies and uses thereofMADDON PAUL J·Filed 2010·Granted Jun 25, 2013·50 cites·31 claims
- 0495US9493565B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2014·Granted Nov 15, 2016·50 cites·8 claims
- 0595US8779108B2Targeted binding agents against B7-H1QUEVA CHRISTOPHE·Filed 2010·Granted Jul 15, 2014·452 cites·31 claims
- 0695US8114965B2Compositions of PSMA antibodiesMADDON PAUL J·Filed 2007·Granted Feb 14, 2012·52 cites·47 claims
- 0795US7285269B2Antibodies directed to tumor necrosis factorAMGEN FREMONT INC·Filed 2003·Granted Oct 23, 2007·101 cites·35 claims
- 0894US8568992B2Antibody categorization based on binding characteristicsWALKER WYNN L·Filed 2012·Granted Oct 29, 2013·53 cites·57 claims
- 0994US7585500B2Fully human monoclonal antibodies to IL-13AMGEN INC·Filed 2005·Granted Sep 8, 2009·36 cites·3 claims
- 1093US9096672B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Aug 4, 2015·16 cites·38 claims
- 1191US8604174B2High affinity fully human monoclonal antibodies to interleukin-8BABCOOK JOHN·Filed 2006·Granted Dec 10, 2013·30 cites·7 claims
- 1291US8012714B2Sequence diversity generation in immunoglobulinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2009·Granted Sep 6, 2011·17 cites·44 claims
- 1391US7968684B2IL-18 binding proteinsABBOTT LAB·Filed 2004·Granted Jun 28, 2011·24 cites·64 claims
- 1490US10400039B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2016·Granted Sep 3, 2019·8 cites·8 claims
- 1590US8858942B2Antibodies directed to ERBB2MEDIMMUNE LTD·Filed 2012·Granted Oct 14, 2014·11 cites·12 claims
- 1689US8350011B2Antibodies to ErbB2MEDIMMUNE LTD·Filed 2007·Granted Jan 8, 2013·10 cites·7 claims
- 1788US9062113B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jun 23, 2015·7 cites·28 claims
- 1886US8206936B2Antibody categorization based on binding characteristicsWALKER WYNN L·Filed 2010·Granted Jun 26, 2012·3 cites·52 claims
- 1986US7994302B2Fully human monoclonal antibodies to IL-13AMGEN INC·Filed 2009·Granted Aug 9, 2011·8 cites·8 claims
- 2085US8119130B2Targeted binding agents directed to KDR and uses thereof—035BARRY SIMON THOMAS·Filed 2008·Granted Feb 21, 2012·14 cites·4 claims
- 2185US7572444B2Binding proteins specific for human matriptaseAMGEN FREMONT INC·Filed 2005·Granted Aug 11, 2009·12 cites·17 claims
- 2283US8617845B2Sequence diversity generation in immunoglobulinsGALLO MICHAEL·Filed 2011·Granted Dec 31, 2013·4 cites·22 claims
- 2383US7754859B2Targeted binding agents directed to PDGFR-alpha and uses thereofASTRAZENECA AB·Filed 2007·Granted Jul 13, 2010·7 cites·18 claims
- 2482US9073998B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Jul 7, 2015·3 cites·88 claims
- 2581US11492411B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2019·Granted Nov 8, 2022·0 cites·20 claims
- 2681US10118968B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Nov 6, 2018·2 cites·54 claims
- 2781US7771951B2Antibody categorization based on binding characteristicsAMGEN FREMONT INC·Filed 2002·Granted Aug 10, 2010·5 cites·52 claims
- 2880US9085624B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jul 21, 2015·2 cites·26 claims
- 2980US2023235062A1Targeted binding agents against b7-h1MEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 3079US8431130B2IL-18 binding proteinsGHAYUR TARIQ·Filed 2010·Granted Apr 30, 2013·2 cites·50 claims
- 3177US10233453B2Generating targeted sequence diversity in fusion proteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2017·Granted Mar 19, 2019·1 cites·18 claims
- 3275US10508153B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2015·Granted Dec 17, 2019·1 cites·61 claims
- 3375US8207306B2Targeted binding agents directed to sonic hedgehog homolog and uses thereofJENKINS DAVID·Filed 2009·Granted Jun 26, 2012·2 cites·24 claims
- 3474US8101178B2Antibodies directed to tumor necrosis factor and uses thereofBABCOOK JOHN S·Filed 2007·Granted Jan 24, 2012·3 cites·21 claims
- 3574US2014178905A1Antibody categorization based on binding characteristicsAMGEN INC·Filed 2013·Application pending·0 cites
- 3673US9718871B2Generating targeted sequence diversity in proteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2013·Granted Aug 1, 2017·2 cites·16 claims
- 3767US11518809B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2019·Granted Dec 6, 2022·0 cites·11 claims
- 3867US10563206B2Generating targeted sequence diversity in fusion proteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2019·Granted Feb 18, 2020·0 cites·16 claims
- 3961US7754433B2Identification of high affinity molecules by limited dilution screeningAMGEN FREMONT INC·Filed 2002·Granted Jul 13, 2010·3 cites·20 claims
- 4060US9914929B2Generating targeted sequence diversity in fusion proteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2013·Granted Mar 13, 2018·0 cites·17 claims
- 4160US8697664B2Targeted binding agents directed to PDGRF-alpha and uses thereofLAING NAOMI·Filed 2010·Granted Apr 15, 2014·1 cites·23 claims
- 4258US2012107324A1TARGETED BINDING AGENTS DIRECTED TO a5ß1 AND USES THEREOFEBERLEIN CATHERINE ANNE·Filed 2009·Application pending·0 cites
- 4357US2009324601A1Targeted binding agents directed to pdgfr-alpha and uses thereofASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4455US2014088296A1Il-18 binding proteinsABBOTT LAB·Filed 2013·Application pending·0 cites
- 4552US8569459B2Targeted binding agents directed to sonic hedgehog homolog and uses thereofJENKINS DAVID·Filed 2012·Granted Oct 29, 2013·0 cites·20 claims
- 4652US2014105905A1High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such AntibodiesAMGEN FREMONT INC·Filed 2013·Application pending·0 cites
- 4750US2012114667A1TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOFEBERLEIN CATHERINE ANNE·Filed 2009·Application pending·0 cites
- 4846US2017334970A1Generating Targeted Sequence Diversity in ProteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2017·Application pending·0 cites
- 4944US2005100965A1IL-18 binding proteinsFiled 2003·Application pending·0 cites
- 5044US2013236931A1Sequence diversity generation in immunoglobulins and other proteinsGALLO MICHAEL·Filed 2013·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →